Saxonov Serge's Insider Trades & SAST Disclosures
Saxonov Serge's most recent trade in 10x Genomics Inc - Ordinary Shares - Class A was a trade of 171,428 Class A Common Stock done . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Saxonov Serge.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 171,428 | 1,092,968 (5%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 17,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Feb 2025 | 50,000 | 921,540 (4%) | 0% | 1.2 | 60,000 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.63 per share. | 28 Feb 2025 | 7,942 | 871,540 (4%) | 0% | 10.6 | 84,393 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.07 per share. | 24 Feb 2025 | 5,092 | 879,482 (4%) | 0% | 11.1 | 56,346 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 23 Dec 2024 | 12,000 | 884,574 (4%) | 0% | 1.2 | 14,400 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2024 | 12,000 | 67,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.69 per share. | 21 Nov 2024 | 6,693 | 872,574 (4%) | 0% | 13.7 | 91,612 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Nov 2024 | 1,850 | 879,267 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2024 | 1,350 | 881,117 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 22 Aug 2024 | 6,749 | 882,467 (4%) | 0% | 22.5 | 152,053 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 May 2024 | 425 | 889,216 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.30 per share. | 22 May 2024 | 4,877 | 889,641 (4%) | 0% | 24.3 | 118,529 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 88,854 | 894,518 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Mar 2024 | 1,086 | 805,664 (3%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 44.00 per share. | 04 Mar 2024 | 4,660 | 842,900 (3%) | 0% | 44.0 | 205,021 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 46.34 per share. | 22 Feb 2024 | 2,821 | 847,560 (3%) | 0% | 46.3 | 130,737 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.58 per share. | 15 Feb 2024 | 3,300 | 852,081 (4%) | 0% | 48.6 | 160,300 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.43 per share. | 15 Feb 2024 | 1,700 | 850,381 (3%) | 0% | 49.4 | 84,032 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.53 per share. | 09 Feb 2024 | 1,000 | 855,381 (4%) | 0% | 49.5 | 49,530 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.10 per share. | 16 Jan 2024 | 2,965 | 857,416 (4%) | 0% | 45.1 | 133,712 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.65 per share. | 16 Jan 2024 | 1,035 | 856,381 (4%) | 0% | 45.6 | 47,244 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 27 Dec 2023 | 14,935 | 860,381 (4%) | 0% | 1.2 | 17,922 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Saxonov Serge | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2023 | 14,935 | 79,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Saxonov Serge | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.15 per share. | 14 Dec 2023 | 1,700 | 845,446 (3%) | 0% | 55.1 | 93,749 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.39 per share. | 14 Dec 2023 | 300 | 847,146 (3%) | 0% | 54.4 | 16,316 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 45.78 per share. | 22 Aug 2023 | 3,757 | 864,093 (4%) | 0% | 45.8 | 172,000 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 14 Aug 2023 | 1,983 | 867,867 (4%) | 0% | 50.1 | 99,355 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 50.41 per share. | 14 Aug 2023 | 17 | 867,850 (4%) | 0% | 50.4 | 857 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.03 per share. | 19 Jul 2023 | 40,000 | 869,850 (4%) | 0% | 60.0 | 2,401,088 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jul 2023 | 20,845 | 32,478 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 19 Jul 2023 | 20,845 | 909,850 (4%) | 0% | 5.0 | 105,059 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.37 per share. | 14 Jul 2023 | 1,149 | 889,005 (4%) | 0% | 58.4 | 67,064 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.61 per share. | 14 Jul 2023 | 851 | 890,154 (4%) | 0% | 57.6 | 49,026 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.53 per share. | 14 Jun 2023 | 1,209 | 891,056 (4%) | 0% | 58.5 | 70,758 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 14 Jun 2023 | 740 | 892,265 (4%) | 0% | 57.5 | 42,553 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Jun 2023 | 185 | 893,005 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 59.16 per share. | 14 Jun 2023 | 51 | 891,005 (4%) | 0% | 59.2 | 3,017 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 19 May 2023 | 2,068 | 893,190 (4%) | 0% | 55.1 | 113,867 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.06 per share. | 19 May 2023 | 534 | 895,258 (4%) | 0% | 55.1 | 29,404 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 19 May 2023 | 460 | 27 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.57 per share. | 15 May 2023 | 1,506 | 895,792 (4%) | 0% | 53.6 | 80,669 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 15 May 2023 | 494 | 897,298 (4%) | 0% | 52.7 | 26,032 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 53.61 per share. | 14 Apr 2023 | 1,641 | 898,151 (4%) | 0% | 53.6 | 87,976 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.64 per share. | 14 Apr 2023 | 283 | 897,868 (4%) | 0% | 54.6 | 15,462 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 55.28 per share. | 14 Apr 2023 | 76 | 897,792 (4%) | 0% | 55.3 | 4,201 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 72,773 | 72,773 | - | - | Performance - based Restricted Stock Units | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 72,773 | 72,773 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2023 | 36,387 | 899,792 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.81 per share. | 14 Mar 2023 | 1,697 | 863,708 (4%) | 0% | 48.8 | 82,824 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 49.28 per share. | 14 Mar 2023 | 303 | 863,405 (4%) | 0% | 49.3 | 14,932 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 07 Mar 2023 | 260 | 487 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 47.75 per share. | 22 Feb 2023 | 1,941 | 909,715 (4%) | 0% | 47.8 | 92,689 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 12 Dec 2022 | 3,000 | 911,656 (4%) | 0% | 1.2 | 3,600 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 3,000 | 38,035 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2022 | 1,740 | 747 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 22 Nov 2022 | 1,887 | 974,926 (4%) | 0% | 34.1 | 64,281 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 34.06 per share. | 22 Nov 2022 | 789 | 976,813 (4%) | 0% | 34.1 | 26,877 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 213,112 | 213,112 | - | - | Performance-based Restricted Stock Units | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2022 | 142,075 | 142,075 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Sep 2022 | 11,500 | 41,035 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 12 Sep 2022 | 11,500 | 977,602 (4%) | 0% | 1.2 | 13,800 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 35.19 per share. | 23 Aug 2022 | 2,715 | 966,102 (4%) | 0% | 35.2 | 95,544 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jun 2022 | 1,651 | 2,487 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 48.76 per share. | 23 May 2022 | 2,656 | 968,817 (4%) | 0% | 48.8 | 129,516 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 146,827 | 146,827 | - | - | Stock Option (Right to Buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 58,731 | 971,473 (4%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 78.60 per share. | 22 Feb 2022 | 551 | 912,742 (4%) | 0% | 78.6 | 43,309 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 90.30 per share. | 08 Feb 2022 | 4,503 | 915,690 (4%) | 0% | 90.3 | 406,618 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 89.19 per share. | 08 Feb 2022 | 4,200 | 920,193 (4%) | 0% | 89.2 | 374,590 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2022 | 3,038 | 42,521 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 08 Feb 2022 | 3,038 | 925,293 (4%) | 0% | 11.5 | 34,876 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 91.04 per share. | 08 Feb 2022 | 2,397 | 913,293 (4%) | 0% | 91.0 | 218,228 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 88.17 per share. | 08 Feb 2022 | 900 | 924,393 (4%) | 0% | 88.2 | 79,349 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 140.96 per share. | 04 Jan 2022 | 5,368 | 927,787 (4%) | 0% | 141.0 | 756,663 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 139.82 per share. | 04 Jan 2022 | 3,100 | 933,155 (4%) | 0% | 139.8 | 433,444 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 04 Jan 2022 | 3,037 | 937,255 (4%) | 0% | 11.5 | 34,865 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2022 | 3,037 | 45,559 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 141.72 per share. | 04 Jan 2022 | 2,932 | 924,855 (4%) | 0% | 141.7 | 415,517 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 144.78 per share. | 04 Jan 2022 | 1,400 | 922,755 (4%) | 0% | 144.8 | 202,695 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.86 per share. | 04 Jan 2022 | 1,000 | 936,255 (4%) | 0% | 138.9 | 138,864 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 143.11 per share. | 04 Jan 2022 | 700 | 924,155 (4%) | 0% | 143.1 | 100,179 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 145.33 per share. | 04 Jan 2022 | 500 | 922,255 (4%) | 0% | 145.3 | 72,663 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Dec 2021 | 56,363 | 934,218 (4%) | 0% | 1.2 | 67,636 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2021 | 56,363 | 52,535 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Dec 2021 | 360 | 4,138 (0%) | 0% | 0 | Class A Common Stock | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.05 per share. | 07 Dec 2021 | 6,480 | 880,979 (4%) | 0% | 147.0 | 952,882 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 5,209 | 53,323 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 07 Dec 2021 | 5,209 | 889,818 (4%) | 0% | 5.0 | 26,253 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 143.36 per share. | 07 Dec 2021 | 3,187 | 888,702 (4%) | 0% | 143.4 | 456,881 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2021 | 3,037 | 48,596 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.48 per share. | 07 Dec 2021 | 3,037 | 892,855 (4%) | 0% | 11.5 | 34,865 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 147.96 per share. | 07 Dec 2021 | 2,370 | 878,609 (4%) | 0% | 148.0 | 350,673 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 142.40 per share. | 07 Dec 2021 | 766 | 891,889 (4%) | 0% | 142.4 | 109,075 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.60 per share. | 07 Dec 2021 | 754 | 877,855 (4%) | 0% | 148.6 | 112,043 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 144.27 per share. | 07 Dec 2021 | 672 | 888,030 (4%) | 0% | 144.3 | 96,950 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 145.79 per share. | 07 Dec 2021 | 571 | 887,459 (4%) | 0% | 145.8 | 83,247 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 138.86 per share. | 07 Dec 2021 | 200 | 892,655 (4%) | 0% | 138.9 | 27,772 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 148.38 per share. | 22 Nov 2021 | 772 | 884,609 (4%) | 0% | 148.4 | 114,550 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 161.06 per share. | 02 Nov 2021 | 5,946 | 891,194 (4%) | 0% | 161.1 | 957,687 | Class A Common Stock |
| 10x Genomics Inc - Ordinar... | Serge Saxonov | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 161.94 per share. | 02 Nov 2021 | 5,613 | 885,581 (4%) | 0% | 161.9 | 908,962 | Class A Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges